Strategy and Solutions
The client is a top-20 global biopharmaceutical company operating multiple research and development labs across regions. The organization relied on 15 siloed lab systems, leading to fragmented data, inconsistent workflows, and compliance challenges. Limited integration across instruments and systems impacted productivity and slowed down research outcomes. To streamline operations and ensure regulatory compliance, the organization partnered with Zymr.
The organization operated with multiple disconnected LIMS and ELN systems across labs, creating data silos and limiting collaboration between teams. Researchers faced difficulties in accessing unified data, resulting in delays and inefficiencies in sample tracking and analysis.
Manual workflows and lack of automation increased the risk of errors and reduced overall lab productivity. Inconsistent data formats and lack of standardization further complicated reporting and compliance processes.
Regulatory compliance, including 21 CFR Part 11 requirements, was difficult to maintain due to fragmented systems and limited audit trails. Preparing for audits required significant manual effort, consuming valuable time and resources.
The client needed a unified, scalable LIMS/ELN platform that could integrate instruments, automate workflows, ensure compliance, and improve overall lab efficiency.
Zymr enabled the transformation of fragmented lab environments into a unified digital platform, improving efficiency, compliance, and data accessibility across global labs.
Zymr implemented a unified LIMS/ELN platform tailored to biopharma research workflows, enabling seamless integration, automation, and compliance.
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)